Soon Jae Park

This inventor holds 16 USPTO granted patents and 11 published patent applications, plus 6 CIPO patents and 10 EPO patents. Top assignees: Alteogen, Inc., Cj Healthcare Corporation, Lucky Corporation Co., Ltd.. Active years: 1996-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Soon Jae Park. Retrieved from https://idiyas.com/inventor/soon-jae-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 11)

% Patents Active = 87.5

CIPO Patents = 6 (Patent Applications = 7)

EPO Patents = 10 (Patent Applications = 22)

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 33(Granted Patents)

Location History:

Daejoen, KR (2016)
Daejeon, KR (1996 - 2024)

Company Filing History:

Cj Healthcare Corporation

patents

1 out of 5

Lucky Corporation Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 1996-2026

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12618055 - Hyaluronidase variants with improved stability and pharmaceutical composition comprising the same (2026-05-05),

2. 12570766 - PHARMACEUTICAL COMPOSITION FOR SUBCUTANEOUS ADMINISTRATION CONTAINING HUMAN HYALURONIDASE PH20 VARIANT AND DRUG (2026-03-10),

3. 12371683 - Hyaluronidase variants and pharmaceutical composition comprising the same (2025-07-29),

4. 12221638 - Method for producing recombinant hyaluronidase (2025-02-11),

5. 12090210 - Antibody-drug conjugate comprising modified antibody (2024-09-17),

6. 11981719 - Growth hormone receptor antagonists and fusion proteins thereof (2024-05-14),

7. 11866492 - Antibody specifically binding to FOLR1 and uses thereof (2024-01-09),

8. 11414476 - Method for producing fusion protein having IgG Fc domain (2022-08-16),

9. 11235065 - Antibody-drug conjugate comprising modified antibody (2022-02-01),

10. 9982032 - Stable liquid formulation of fusion protein with IgG Fc domain (2018-05-29),

11. 9902753 - Method of purifying a long-acting human growth hormone (2018-02-27),

12. 9821059 - Composition for stabilizing protein and pharmaceutical formulation comprising the same (2017-11-21),

13. 9814782 - Modified antibody in which motif comprising cysteine residue is bound, modified antibody-drug conjugate comprising the modified antibody, and production method for same (2017-11-14),

14. 9474803 - Composition for stabilizing fusion protein in which protein and FC domain are fused (2016-10-25),

15. 9051395 - Alpha-1 antitrypsin variant, preparation method thereof and use thereof (2015-06-09),

Title: The Innovations of Soon Jae Park

Introduction

Soon Jae Park is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of protein engineering, particularly in the development of hyaluronidase variants. With a total of 16 patents to his name, Park's work has the potential to impact various pharmaceutical applications.

Latest Patents

One of Park's latest patents focuses on hyaluronidase variants and pharmaceutical compositions that enhance enzymatic activity and thermal stability. This invention specifically addresses the hydrolysis of hyaluronic acid, which is crucial in many medical applications. The patent details the creation of PH20 variants that include specific amino acid substitutions, enhancing their functionality. Another notable patent involves a method for producing recombinant hyaluronidase, which optimizes production conditions to improve yield and activity.

Career Highlights

Throughout his career, Soon Jae Park has worked with notable companies such as Alteogen, Inc. and Lucky Corporation Co., Ltd. His expertise in protein engineering has positioned him as a key figure in the development of innovative pharmaceutical solutions.

Collaborations

Park has collaborated with esteemed colleagues, including Hye-Shin Chung and Sunbae Lee. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of scientific knowledge.

Conclusion

Soon Jae Park's contributions to the field of protein engineering and his numerous patents highlight his role as a leading inventor. His work continues to pave the way for advancements in pharmaceutical technology.

Profile summary based on public USPTO records.